Cargando…
Evolution of Knowledge in the Treatment of Long-Standing Atrial Fibrillation in a UK Tennis Champion
During the last several decades, there have been major advances in the evolution of drug therapies for the rate management of atrial fibrillation (AF). Initially, the drug of choice was digoxin but currently, the drug of choice is beta-adrenergic blockers. Drug therapies for stroke prevention in AF...
Autores principales: | Krishnaswamy, Shiv, Rane, Manas, Gaziano, J. Michael, Hennekens, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144072/ https://www.ncbi.nlm.nih.gov/pubmed/34055502 http://dx.doi.org/10.7759/cureus.14624 |
Ejemplares similares
-
Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation
por: Kiedrowicz, Radoslaw M., et al.
Publicado: (2022) -
Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review
por: Ghattas, Kyrillos N, et al.
Publicado: (2020) -
Obesity phenotypes and their relationships with atrial fibrillation
por: Tsai, Szu-Ying, et al.
Publicado: (2021) -
Outcome of Atrial Fibrillation in Patients With Sepsis
por: Afzal, Benish, et al.
Publicado: (2021) -
A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)